Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
|
|
- Jasper McDowell
- 5 years ago
- Views:
Transcription
1 Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
2
3 Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers clients comprehensive legal expertise paired with a practical understanding of commercial realities. With a multidisciplinary and integrated global practice, we provide our healthcare and life sciences clients with leading edge transactional advice, expertise on intellectual property intensive matters and deep litigation experience that is critical to the successful execution and consummation of deals and the resolution of disputes. As the following pages demonstrate, Sullivan & Cromwell s Healthcare and Life Sciences Group has had the privilege of working on a number of transactions that have transformed the healthcare industry. We are grateful that our clients have trusted us with many of the industry s most significant matters. We look forward to working with existing and new clients and bringing to bear our industry expertise and experience in what promises to be another exciting year in dealmaking as companies continue to position themselves strategically in an ever-evolving industry. 1
4 Timeline of S&C s Headline Healthcare and Life Sciences Transactions Sprout Pharmaceuticals S&C client Sprout Pharmaceuticals (U.S.) completes its $1 billion acquisition by Valeant Pharmaceuticals (Canada) New WuXi Life Science S&C client Ally Bridge Group Capital Partners (Hong Kong), as leader of the consortium, completes its investment and the consortium s beneficial ownership of New WuXi Life Science resulting from the merger between WuXi PharmaTech (Cayman) and New WuXi Life Science Limited (China) and its subsidiary WuXi Merger Limited (China) Stemcentrx S&C client Stemcentrx (U.S.) completes its $9.8 billion acquisition by AbbVie (U.S.) Teva Pharmaceutical Industries S&C client Teva Pharmaceutical Industries (Israel) completes its $40.5 billion acquisition of Allergan Generics (Ireland) Royal Philips S&C client Royal Philips (Netherlands) completes its acquisition of Wellcentive (U.S.) OCT NOV DEC JAN FEB MAR APR MAY JUNE JULY Concordia Healthcare S&C client Concordia Healthcare (Canada) completes its $3.5 billion acquisition of Amdipharm Mercury Limited (U.K.) Cyberonics S&C client Cyberonics (U.S.) completes its $1.5 billion merger with Sorin (Italy) to create LivaNova (U.K.) Dyax S&C client Dyax (U.S.) completes its $5.9 billion acquisition by Shire (Ireland) Stryker S&C client Stryker (U.S.) completes its $2.8 billion acquisition of Sage Products (U.S.) from Madison Dearborn Partners (U.S.) Impax Laboratories S&C client Impax Laboratories (U.S.) completes its $586 million acquisition of generic products from Teva Pharmaceutical Industries (Israel) and affiliates of Allergan (Ireland) Winner, Dealmaker of the Week: Sullivan & Cromwell s Alison Ressler: Valeant acquisition of Salix THE AMERICAN LAWYER, FEBRUARY 2015 Winner, Dealmaker of the Year: Sullivan & Cromwell s Matthew Hurd: Bayer acquisition of the consumer care business of Merck THE AMERICAN LAWYER, MARCH 2015 Winners, Dealmakers of the Week, Sullivan & Cromwell s Keith Pagnani and Melissa Sawyer: UnitedHealth subsidiary OptumRx s combination with Catamaran Corporation THE AMERICAN LAWYER, APRIL 2015 Winners, Dealmakers of the Week, Sullivan & Cromwell s Matt Hurd and Krishna Veeraraghavan: Synageva BioPharma acquisition by Alexion Pharmaceuticals THE AMERICAN LAWYER, MAY
5 Astellas Pharma S&C advises client Astellas Pharma (Japan) in connection with Pfizer s (U.S.) $14 billion merger agreement with Medivation (U.S.) Verily Life Sciences S&C client Verily Life Sciences (U.S.), an Alphabet (U.S.) company, announces its partnership with Temasek (Singapore) Terumo Corporation S&C client Terumo Corporation (Japan) announces its $1.12 billion acquisition of certain products from Abbott Laboratories (U.S.) and St. Jude Medical (U.S.) INC Research S&C client INC Research (U.S.) announces its $7.4 billion merger of equals with inventiv Health (U.S.) AUG SEPT OCT NOV DEC JAN FEB MAR APR MAY 2017 Bayer S&C client Bayer (Germany) announces its $66 billion acquisition of Monsanto (U.S.) Praxair S&C client Praxair (U.S.) announces its $67 billion merger of equals with Linde (Germany) Royal Philips S&C client Royal Philips (Netherlands) announces its participation in a $45 million private placement by Corindus Vascular Robotics (U.S.) of its common stock Baker Bros. Advisors S&C client Baker Bros. Advisors (U.S.), the largest shareholder in BeiGene (China), announces BeiGene s joint venture with Guangzhou Development District to establish biologics facility in China Royal Philips S&C client Royal Philips (Netherlands) announces its agreement to acquire Respiratory Technologies (U.S.) The Daily Journal named Alison Ressler to its list of Top 100 Women in Law feature, recognizing her for her work advising Valeant Pharmaceuticals International Inc. in its attempted bid to acquire Allergan Inc. for $56 billion, a unique, high-profile transaction that ultimately did not close. Alison also advised Valeant in its acquisition of Salix Pharmaceuticals Ltd for $15.8 billion, one of many recent big deals in the pharmaceutical industry. THE DAILY JOURNAL, MAY 2015 Winner, Dealmaker of the Week: Sullivan & Cromwell s Joe Frumkin: Teva acquisition of Allergan Generics THE AMERICAN LAWYER, JULY 2015 Winner, Dealmaker of the Year, Sullivan & Cromwell s Matt Hurd: Bayer acquisition of Monsanto THE AMERICAN LAWYER, MARCH
6 Other Healthcare Highlights In addition, S&C was involved in the following transactions, which showcase our experience working with a diverse set of participants in the healthcare and life sciences industry. From representing pharmaceutical, biotechnology and life sciences companies, to working directly with leading medical information system and technology specialists, as well as healthcare services and providers, Sullivan & Cromwell s industry experience is vast. SAMPLE REPRESENTATIONS OF PRINCIPALS: AbbVie Inc. (U.S.) in its $55 billion withdrawn acquisition of Shire (Ireland) Alcon (Switzerland) and Alcon s Independent Directors in connection with the sale of Nestlé s Alcon stake to Novartis (Switzerland) and Novartis acquisition of the remaining publicly held minority interest in Alcon for $52.9 billion AMAG Pharmaceuticals (U.S.) in the proxy fight between AMAG and MSMB Capital (U.S.) Amgen (U.S.) in its: $10.5 billion acquisition of Onyx Pharmaceuticals (U.S.) $1.16 billion acquisition of Micromet (U.S.) $415 million acquisition of decode Genetics (Iceland) $315 million acquisition of Kai Pharmaceuticals (U.S.) Baker Bros. Advisors (U.S.) as lead investor in the $100 million purchase of a newly authorized class of Series A-2 Convertible Preferred Shares of BeiGene (China) Bayer (Germany) in its: $14.2 billion acquisition of the consumer care business of Merck (U.S.) $2.9 billion acquisition of Algeta (Norway) Concordia Healthcare (Canada) in its $1.2 billion acquisition of Covis Pharma (Switzerland) and Covis Injectables (Switzerland) CONMED (U.S.) in its: $265 million acquisition of SurgiQuest (U.S.) settlement with Voce Capital Management (U.S.) $22.5 million acquisition of Viking Systems (U.S.) $147 million transaction with Musculoskeletal Transplant Foundation (MTF) (U.S.) to obtain (i) exclusive, worldwide promotion rights with respect to MTF s human tissue grafts for use within the field of sports medicine, and (ii) an exclusive, worldwide license to MTF s platelet-rich plasma technology and products Cypress Bioscience (U.S.) in the proxy fight between Cypress and Ramius (U.S.) and Royalty Pharma (U.S.) CVS Caremark (U.S.) in its: 50/50 joint venture with Cardinal Health (U.S.) $2.1 billion acquisition of Coram (U.S.) CVS Health (U.S.) in its $12.7 billion acquisition of Omnicare (U.S.) Endo International (Ireland) in its $2.6 billion acquisition of Auxilium Pharmaceuticals (U.S.) Google Life Sciences (U.S.) in its formation as the first of the Alphabet companies, Verily Life Sciences (U.S.), created as a result of Google Inc. s (U.S.) corporate reorganization Idenix Pharmaceuticals, Inc. (U.S.) in its $3.85 billion acquisition by Merck (U.S.) Impax Laboratories (U.S.) in its: $700 million acquisition of Tower Holdings (U.S.) including operating subsidiaries CorePharma (U.S.), Amedra Pharmaceuticals (U.S.), and Lineage Therapeutics (U.S.) acquisition of two pharmaceutical products from Actavis (Ireland) Ipsen Pharma (France) in its global license, development and commercialization agreements for two investigational drugs in late-stage development for hemophilia with its strategic partner, Inspiration Biopharmaceuticals (U.S.) LabCorp (U.S.) in its $6.1 billion acquisition of Covance (U.S.) Medco Health Solutions (U.S.) in its $34.3 billion acquisition by Express Scripts (U.S.) Optimer Pharmaceuticals (U.S.) in its acquisition by Cubist Pharmaceuticals (U.S.) 4
7 Paion (Germany) in the sale of its remaining rights in a Phase III compound called Desmotephlase to H. Lundbeck (Denmark) for $27 million Perrigo Company (U.S.) in its $8.6 billion acquisition of Elan Pharmaceuticals (Ireland) Pershing Square (U.S.) in its investment in Zoetis (U.S.) Pharmasset (U.S.) in its $11 billion acquisition by Gilead Sciences (U.S.) Royal Philips (Netherlands) in its: $1 billion acquisition of Volcano Corporation (U.S.) acquisition of certain key assets of medsage Technologies (U.S.) $5.1 billion acquisition of Respironics, Inc. (U.S.) Stryker (U.S.) in its $764 million cash offer to acquire all the shares and share options of Trauson Holdings Company (China) Synageva BioPharma Corp. (U.S.) in its $8.4 billion acquisition by Alexion Pharmaceuticals (U.S.) Teva Pharmaceuticals Industries (Israel) in its $50.5 billion proposed acquisition of Mylan (U.K.) (later terminated) UnitedHealth Group (U.S.) in its: pharmacy care business OptumRx s (U.S.) $12.8 billion combination with Catamaran Corporation (U.S.) $4.9 billion acquisition of Amil articipações (Brazil) acquisition of XLHealth (U.S.) Valeant Pharmaceuticals (Canada) in its: $15.8 billion acquisition of Salix Pharmaceuticals (U.S.) divesture of all North American commercialization rights to RUCONEST, including all rights in the US, Mexico and Canada, to Pharming Group (Netherlands) for an aggregate consideration of up to $125 million $55 billion unsolicited offer to acquire Allergan (U.S.) (later terminated) $1.4 billion sale of aesthetic products to Galderma (Switzerland) $475 million acquisition of PreCision Dermatology (U.S.) $2.6 billion acquisition of Medicis (U.S.) $112.5 million acquisition of the business relating to the Visudyne product (U.S.) from QLT (Canada) acquisition of Eyetech (U.S.) Veritas Capital (U.S.) in its $1.25 billion acquisition of the healthcare business of Thomson Reuters (U.S.) SAMPLE REPRESENTATIONS OF FINANCIAL ADVISERS: AmerisourceBergen Counsel to financial adviser to AmerisourceBergen (U.S.) in its $2.5 billion acquisition of MWI Veterinary Supply (U.S.) ARIAD Pharmaceuticals Counsel to financial adviser to ARIAD Pharmaceuticals (U.S.) in its $5.2 billion acquisition by Takeda Pharmaceutical Company (Japan) Auxilium Pharmaceuticals Counsel to financial adviser to Auxilium Pharmaceuticals (U.S.) in its $635 million acquisition of Actient Holdings (U.S.) Covidien Counsel to financial adviser to Covidien (U.S.) in its $42.9 billion acquisition by Medtronic (U.S.) HealthSouth Corporation Counsel to financial adviser to HealthSouth Corporation (U.S.) in its $730 million acquisition of the operations of Reliant Hospital Partners (U.S.) and affiliated entities Hill-Rom Holdings Counsel to financial adviser to Hill-Rom Holdings (U.S.) $2.1 billion acquisition of Welch Allyn (U.S.) Hyperion Therapeutics Counsel to financial adviser to Hyperion Therapeutics (U.S.) in its $1.1 billion acquisition by Horizon Pharma (Ireland) Patheon Counsel to financial adviser to Patheon (Netherlands) in its $7.2 billion acquisition by Thermo Fisher Scientific (U.S.) Patterson Companies Counsel to financial adviser to Patterson Companies (U.S.) in its $1.1 billion acquisition of Animal Health International (U.S.) STERIS Corporation Counsel to financial adviser to STERIS Corporation (U.S.) in its $1.9 billion acquisition of Synergy Health (U.K.) St. Jude Medical Counsel to financial advisor to St. Jude Medical (U.S.) in its $3.4 billion acquisition of Thoratec (U.S.) Tornier Counsel to financial adviser to Tornier (Netherlands) in its $3.3 billion merger agreement with Wright Medical Group (U.S.) 5
8 Healthcare and Life Sciences Practice Sullivan & Cromwell offers clients comprehensive legal expertise paired with a practical understanding of commercial reality. Our pragmatic approach and multidisciplinary and integrated global practice allow us to provide our healthcare and life sciences clients with a full range of legal services. Clients benefit not only from our understanding of the complexities of the industry but also from our market-leading experience and strength in M&A, capital markets, litigation, real estate, tax and intellectual property, where we partner with clients to help them shape and carry out their strategic goals. Winner, Life Sciences MVP: Sullivan & Cromwell s Krishna Veeraraghavan LAW360, NOVEMBER 2016, 2015 Winner, Life Sciences MVP: Sullivan & Cromwell s Matt Hurd LAW360, NOVEMBER 2015 Winner, Life Sciences Group of The Year: Sullivan & Cromwell LAW360, 2015 Winner, Life Sciences MVP: Sullivan & Cromwell s Matt Hurd LAW360, DECEMBER 2014 In the life sciences and pharmaceuticals space, Keith Pagnani and Matthew Hurd are making a significant impression. LEGAL 500 US, 2014 Winner, Life Sciences MVP: Sullivan & Cromwell s Frank Aquila LAW360, DECEMBER
9 S&C s Longstanding History as a Leader in Healthcare M&A S &C has played a leading role in the consolidation of the healthcare sector, advising on six of the 10 largest healthcare M&A deals to date. ACQUIRER TARGET DATE VALUE ($ millions) Pfizer (U.S.) Warner-Lambert (U.S.) ,771 Glaxo Wellcome* (U.K.) SmithKline Beecham (U.K.) ,775 Actavis (U.S.) Allergan (Ireland) ,404 Bayer* (Germany) Monsanto (U.S.) ,843 Sanofi-Synthelabo (France) Aventis* (France) ,657 Pfizer (U.S.) Wyeth (U.S.) ,480 Pfizer (U.S.) Pharmacia* (U.S.) ,704 Novartis (Switzerland) Alcon* (Switzerland) ,955*** Anthem (U.S.) Cigna (U.S.) ,383 Medtronic (U.S) Covidien** (U.S) ,922 Source: Thomson Reuters, May 2, 2017 *Representing the company identified **Representing the financial adviser to the company identified *** Aggregate value of three-step transaction ultimately consummated in 2011 INDUSTRY SECTOR EXPERIENCE Pharmaceuticals and Life Sciences Medtech Health Insurers Healthcare Services 7
10 Practice Contacts Francis J. Aquila Garrard Beeney Steven J. Elliott Matthew M. Friestedt Robert J. Giuffra, Jr John L. Hardiman Matthew G. Hurd Co-Head Healthcare & Life Sciences Stephen M. Kotran Nader A. Mousavi Palo Alto Rita-Anne O Neill Los Angeles oneillr@sullcrom.com Keith A. Pagnani Co-Head Healthcare & Life Sciences pagnanik@sullcrom.com Alison S. Ressler Los Angeles resslera@sullcrom.com George J. Sampas sampasg@sullcrom.com Melissa Sawyer sawyerm@sullcrom.com Karen Patton Seymour seymourk@sullcrom.com Krishna Veeraraghavan veeraraghavank@sullcrom.com Eric Krautheimer Los Angeles krautheimere@sullcrom.com 8 Copyright 2017 Sullivan & Cromwell LLP LG4690 Attorney Advertising. Prior results do not guarantee a similar outcome.
11
12 new york. washington, d.c.. los angeles. palo alto london. paris. frankfurt. brussels tokyo. hong kong. beijing. melbourne. sydney
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationHealthcare and Life Sciences Group. Mergers & Acquisitions
Healthcare and Life Sciences Group Mergers & Acquisitions Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Sullivan & Cromwell LLP 2013 LG4690 Prior results do not guarantee a similar outcome. Through decades of experience in many of the transactions
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationCorwin v. KKR Financial Holdings LLC
Delaware Supreme Court Affirms That an Uncoerced and Fully Informed Disinterested Stockholder Vote Reduces the Standard of Review in a Merger Without a Controlling Stockholder to Business Judgment In an
More informationPwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update
PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease
More informationU.S. Mergers and Acquisitions
U.S. Mergers and Acquisitions Industry depth Notable quotes Addressing your needs At the forefront of industry-specific issues, ranging from unique compliance / risk issues to industrydriven transaction
More informationM&A Year in Review: Trends and Highlights from 2014
(Actual image used will be more applicable to the webinar subject matter) M&A Year in Review: Trends and Highlights from 2014 April 18, 2015 Presenter: Tasha Hailey Hutchins, Esq. Senior Editor, Practical
More informationShareholder Proposal to Separate Roles of Chair and CEO Fails at JPMorgan by a Wide Margin
Shareholder Proposal to Separate Roles of Chair and CEO Fails at JPMorgan by a Wide Margin Large Majority of Votes Cast Against the Proposal; Reflects Thoughtful Shareholder Consideration of Actual CEO
More informationJanuary Bob DeSutter Managing Director Co-Head of Health Care
January 2007 Dear Friends and Clients, For much of our 112 year history, serving innovative health care companies has been an important part of our mission at Piper Jaffray. Our goal is to be lead advisor
More informationFrançois G. Laugier's Representative Experience
François G. Laugier's Representative Experience Practice Area: International, Mergers & Acquisitions Key Issues: Acquisitions (For Buyer) Client Type: Foreign Publicly-Traded Naval Technology Company Description:
More informationMara H. Rogers, Partner Norton Rose Fulbright
Mara H. Rogers Partner Norton Rose Fulbright US LLP New York T:+1 212 318 3206 F:+1 212 318 3400 mara.rogers@nortonrosefulbright.com vcard (+Outlook) Related services Corporate, M&A and securities Mergers
More informationLatin America. Pillsbury Winthrop Shaw Pittman LLP pillsburylaw.com
Latin America Pillsbury Winthrop Shaw Pittman LLP pillsburylaw.com Latin America Practice Pillsbury Winthrop Shaw Pittman LLP Overview Decades of Experience in Latin America Pillsbury s Latin America practice
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.
More informationPurvi B. Maniar Member of the Firm
Purvi B. Maniar Member of the Firm New York 250 Park Avenue New York, New York 10177 Tel: 212-351-3757 Fax: 212-878-8600 St. Louis Tel: 314-395-2775 pmaniar@ebglaw.com PURVI B. MANIAR is a Member of the
More informationMonetizing Early-Stage R&D Assets. March 18, 2015
Monetizing Early-Stage R&D Assets March 18, 2015 Disclaimer Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated
More informationDorsey A Global Business Law Firm
London Real Estate Dorsey A Global Business Law Firm 2 Dorsey is an international firm with over 550 lawyers in Europe, North America and Asia. Some of the world s most successful companies count on Dorsey
More informationState of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
More informationTECH START-UP CONNECTING ACROSS GEOGRAPHIES
#ML15MayRathon TECH START-UP CONNECTING ACROSS GEOGRAPHIES Andrew Ray, Partner, Washington DC William Perkins, Partner, Boston James Chapman, Partner, Silicon Valley Joseph Statter, Managing Director,
More informationCannabis Practice Group
Cannabis Practice Group McMillan LLP Vancouver Calgary Toronto Ottawa Montréal Hong Kong Cannabis mcmillan.ca Practice Group 1 Medical cannabis is booming and McMillan is at the forefront of developments
More informationWILSON SONSINI GOODRICH & ROSATI
WILSON SONSINI GOODRICH & ROSATI IS PLEASED TO ANNOUNCE THAT THE FOLLOWING ATTORNEYS HAVE BECOME PARTNERS AT THE FIRM. Troy Foster Corporate & Securities, Palo Alto Jessica L. Margolis Litigation, New
More informationNovember 2016, Issue 56
M&A Activity November 2016, Issue 56 Figure 1 Figure 2 - Most Active U.S. Target Industries 3 October 2016 Global +/- From Prior Month U.S. +/- From Prior Month October 2016 Volume (US$B) 549.10 236.47
More informationDecember 2016, Issue 57
M&A Activity December 2016, Issue 57 Figure 1 Figure 2 - Most Active U.S. Target Industries 3 November 2016 Global +/- From Prior Month U.S. +/- From Prior Month November 2016 Volume (US$B) 352.27 (211.79)
More informationNasir, Dao PKM Abdul Partner PwC Legal (Vietnam) Co., Ltd
Nasir, Dao PKM Abdul Partner PwC Legal (Vietnam) Co., Ltd Get in touch Tel. (direct): +84 (8) 3824 0109 nasir.pkm@pwc.com Professional profile Nasir is a partner and the Legal Services Leader in Vietnam.
More informationP r e s e n t a t i o n. We are an independent and China-based corporate law firm. We make sure you successfully reach your goals in China.
P r e s e n t a t i o n We are an independent and China-based corporate law firm. We make sure you successfully reach your goals in China. 01 WHO WE ARE Corporate law firm Local approach Solution driven
More informationMethod of Declaration. Hospitality/Interest/Sponsorship
Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12
More informationNOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA
Press release Baar, 28 January 2008 Attractive portfolio of investments in biotech and medical technology to be opened to the public HBM BioVentures announces further information of its planned IPO on
More informationAmsterdam. allenovery.com
Amsterdam 2 Allen & Overy Amsterdam Companies today have to be able to respond to global trends while still building on strong, local foundations. As a truly global firm, with strong attachment to our
More informationReinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &
More informationDaryn A. Grossman. Proskauer.com. Partner. New York
Contact Daryn A. Grossman Partner New York +1.212.969.3665 dgrossman@proskauer.com Daryn A. Grossman is co-chair of Proskauer s global Corporate Department. She serves as the head of the Life Sciences
More informationBe inspired. Your future with Orrick in Asia
Be inspired Your future with Orrick in Asia Why Join Orrick? Let us give you a few reasons We are a strong and expanding international firm Orrick has more than 1,100 lawyers in 25 offices worldwide. Over
More informationOmeros Raises More Than $63 Million in Financing
Omeros Raises More Than $63 Million in Financing Seattle, WA February 12, 2007 Omeros today announced that it has raised in excess of $63 million in an oversubscribed Series E equity financing. New investors,
More informationTWO NAMES. ONE COMMITMENT TO EXCELLENCE.
MOFO LONDON 2017 All That + Mojo TWO NAMES. ONE COMMITMENT TO EXCELLENCE. Morrison & Foerster is a global firm with exceptional credentials. Our name is synonymous with a commitment to client service that
More informationMergers and Acquisitions/ Private Equity. Providing In-Depth Deal Coverage for Buyers, Sellers, and Investors. Attorney Advertising
Mergers and Acquisitions/ Private Equity Providing In-Depth Deal Coverage for Buyers, Sellers, and Investors Attorney Advertising In every transaction, business perspective informs our legal strategy.
More informationInternational Presence, Local Expertise. Introductory Presentation
International Presence, Local Expertise Introductory Presentation About GlobalM&A Partners Established in 1999 A partnership of 38 leading independent M&A firms Over 200 active dealmakers supported by
More informationStrategic equity investment of C$723 million in Ivanhoe Mines by China-based CITIC Metal has been completed
September 19, 2018 Strategic equity investment of C$723 million in Ivanhoe Mines by China-based CITIC Metal has been completed Zijin Mining also has exercised its anti-dilution rights, raising additional
More informationManatt Digital 2016 REPRESENTATIVE TRANSACTIONS AND CLIENTS
Manatt Digital 2016 REPRESENTATIVE TRANSACTIONS AND CLIENTS Turning optimism into opportunities. Acorn Technologies Series B Financing AktaryTech Counsel to Lead Investor AthliOS Company Formation and
More informationAsia Pacific UK Cross border transactions. Corporate Finance PRECISE. PROVEN. PERFORMANCE.
Asia Pacific UK Cross border transactions PRECISE. PROVEN. PERFORMANCE. Cross border transactions Our services Moore Stephens global network of offices allows us to combine expert knowledge and advice
More informationPartnering and Product Development A Case Study of Inspiration Biopharmaceuticals, Inc.
Partnering and Product Development A Case Study of Inspiration Biopharmaceuticals, Inc. LIFE SCIENCES LAW, PLLC Prepared for Carolina Innovations Seminar The Office of Technology Development at The University
More information1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp
1h 2012 Trends in Terms of U.S. Life Science Venture Financings First Half 2012 Fenwick fenwick & west llp 1h 2012 Trends in Terms of U.S. Life Science Venture Financings First Half 2012 Survey Introduction
More informationFortis to acquire strategic stake in Parkway Holdings, Singapore
PRESS RELEASE Fortis to acquire strategic stake in Parkway Holdings, Singapore Landmark cross border deal in Healthcare sector out of India Move will establish Fortis as Asia s largest hospital network
More informationTRENDS IN IP DISPUTES
ASSOCIATION OF CORPORATE COUNSEL LITIGATION COMMITTEE APRIL 25, 2017 TRENDS IN IP DISPUTES DAVID YURKERWICH MANAGING DIRECTOR IP PRACTICE LEADER 1 AGENDA Patent infringement and IPR filing trends Operating
More informationRobert A. Greising Partner
Robert A. Greising Partner P: (317) 238-6215 F: (317) 636-1507 E: rgreising@kdlegal.com Indianapolis Office One Indiana Square Suite 2800 Indianapolis, IN 46204-2079 Robert Greising serves as a Partner
More information(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K
DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC 27710 Please complete the applicable
More informationEnayat Qasimi. Partner. Experience M Street, NW Suite 450N Washington, DC Phone: Fax:
2018 Whiteford, Taylor & Preston LLP Enayat Qasimi Partner 1800 M Street, NW Suite 450N Washington, DC 20036 Phone: 202.659.6792 Fax: 202.327.6174 Email: eqasimi@wtplaw.com Experience Mr. Qasimi?s practice
More informationRobert A. Greising Partner
Robert A. Greising Partner P: (317) 238-6215 F: (317) 636-1507 E: rgreising@kdlegal.com Indianapolis Office One Indiana Square Suite 2800 Indianapolis, IN 46204-2079 Robert Greising is a Partner in the
More informationGLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationPrivate Equity & Venture Capital.
Private Equity & Venture Capital www.charltonslaw.com 0 Professional Experience Charltons has wide experience in assisting private equity groups in relation to the establishment of investment funds, private
More informationJAPAN M+A A N N u A l r e v i e w
M+A Annual review JAPAN Morrison & Foerster s Tokyo office has the most active M&A practice of any global firm in Japan, handling over $40 billion in M&A transactions in Tokyo in 2012. softbank We represented
More informationSeptember 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board
AGENDA SPECIAL CALLED TELEPHONE MEETING of THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS September 18, 2017 Austin, Texas Page CONVENE THE BOARD IN OPEN SESSION TO RECESS TO EXECUTIVE SESSION PURSUANT
More informationthe practice of law the way it should be
at a glance A 200 attorney Firm with 50 partners in a single office where collaboration and collegiality are valued the practice of law the way it should be 100% attorney pro bono participation for over
More informationFirm Overview. The firm includes 25 professionals, including 19 lawyers and 6 patent agents and technical specialists, of whom 10 hold Ph.D. degrees.
Firm Overview At Lahive, our thinking expands yours. Our lawyers and technical specialists practice at the cutting edge of intellectual property, with special expertise in biotechnology, chemistry, high
More informationPrivate Equity Classification Changes. November 2008
Private Equity Classification Changes November 2008 Private Equity Classification Changes November 2008 On November 1, 2008, VentureXpert, LPXpert and Thomson ONE Banker customers will see changes to the
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationSOLAR. Representing clients across the renewable energy industry. Troutman Sanders LLP. troutman.com
SOLAR Representing clients across the renewable energy industry What clients value Troutman Sanders served as counsel to over 5600 MWs of solar projects in 2016-2017. U.S. News Best Lawyers Our innovative
More informationGreg Nelson. Houston. Practice Areas. Admissions. Education. Partner, Tax Department
Greg Nelson Partner, Tax Department gregnelson@paulhastings.com Greg Nelson is office chair of the firm s Houston office and a partner in the Tax practice of Paul Hastings. He concentrates his practice
More informationPOST EVENT REPORT IP Life Sciences Exchange 2015
POST EVENT REPORT IP Life Sciences Exchange 2015 A vivid cross-section of present IP challenges, interwoven with opportunities to discuss present needs with solution providers. Deputy Head of IP Egis Pharmaceuticals
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar
More informationPrivate Equity to us does not solely consist of preparing tailor-made acquisition, financing and exit structures, as well as developing and negotiatin
Private Equity to us does not solely consist of preparing tailor-made acquisition, financing and exit structures, as well as developing and negotiating, e.g., joint venture, purchase and participation
More informationManatt Digital Media.
MANATT DIGITAL MEDIA 2014 REPRESENTATIVE CLIENTS AND TRANSACTIONS Q. A. Who helps businesses see digital transformation as opportunity, not risk? Manatt Digital Media. Turning ones and zeros into dollars
More informationMichael Evan Ellis. Matters. Proskauer.com. Partner. New York
Contact Michael Evan Ellis Partner New York +1.212.969.3543 mellis@proskauer.com Michael E. Ellis is a partner in the Corporate Department. He is a general corporate lawyer with a focus on public and private
More informationCASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within
More informationPERENNIAL REAL ESTATE HOLDINGS LIMITED
PERENNIAL REAL ESTATE HOLDINGS LIMITED (Incorporated in the Republic of Singapore) (Company Registration No. 200210338M) ENTRY INTO JOINT VENTURE TO INVEST IN HSR HEALTHCARE INTEGRATED MIXED-USE DEVELOPMENTS
More informationLife Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack
C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics,
More informationSmall Business Investment Companies
Small Business Investment Companies Small Business Investment Companies The economy depends on privately held businesses, and privately held businesses need capital to grow. The SBIC (Small Business Investment
More informationUnique. Perspective. Corporate Finance Advice and Investment Banking. Our unique perspective is client-focused rather than transaction-focused.
Unique SM Perspective Our unique perspective is client-focused rather than transaction-focused. Corporate Finance Advice and Investment Banking Welcome to MidMarket Capital Advisors. It is our pleasure
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): Jan 2015 to December 2015 Name: Adam DeVore Title: Instructor in Medicine Address: 2400 Pratt Street, Durham, NC 27705 Please complete the applicable
More informationWell-poised to become a dominant real estate player with potentially the largest portfolio of HSR projects
PRESS RELEASE 3 January 2018 For Immediate Release Perennial Establishes a US$1.2 billion Joint Venture Vehicle with First Close of US$500 million to Invest in HSR Healthcare Integrated Mixed-use Developments
More informationEuropean companies outpace American counterparts in R&D investment growth for the first time in five years
IP/08/1504 Brussels, 15 October 2008 European companies outpace American counterparts in R&D investment growth for the first time in five years R&D investment by EU companies has increased by 8.8% compared
More informationJOHN JACK R. TUPMAN, JR CURRICULUM VITAE
JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant
More informationJean W. Frydman Partner
Jean W. Frydman Partner Princeton, NJ Tel: 609.895.6630 Fax: 609.896.1469 jfrydman@foxrothschild.com A former general counsel for multinational pharmaceutical companies and a multinational retail dietary
More informationAverage M&A Deal Size at Highest Level Since 2004
CONTACTS Ben Veghte NVCA 1.703.778.9292 bveghte@nvca.org Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY MAINTAINS MOMENTUM WITH BEST QUARTER
More informationPwC Deals $119.1B. Executive summary. Global Pharma & Life Sciences Deals Insights Q2 2018
PwC Deals Global Pharma & Life Sciences Deals Insights Q 18 The increase in deal activity in Q 18 sets the stage for a strong second half of the year. Companies continue to review their portfolios for
More informationLife Sciences Regulatory
Life Sciences Regulatory Pharmaceuticals 2018 2 Life Sciences Regulatory Pharmaceuticals 2018 Top ranked in Chambers and Legal 500 for Life Sciences, pharmaceuticals and biotechnology. Allen & Overy LLP
More informationTechnology Licensing
Technology Licensing Nicholas S. Vonortas Department of Economics & Center for International Science and Technology Policy The George Washington University Conference IPR, Innovation and Economic Performance
More information1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.
1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.1 Spinal Cord Stimulator 3.2 Deep Brain Stimulator 3.3 Vagus Nerve Stimulator
More informationSebastian Burckhardt
Sebastian Burckhardt Dr., M.C.J. Attorney at Law and Civil Law Notary Partner Languages: German, English, French, Italian Contact: +41 58 211 33 47, sburckhardt@vischer.com General Due to his interest
More informationA GUIDE TO OUR SECTORS, SERVICES AND LOCATIONS
A GUIDE TO OUR SECTORS, SERVICES AND LOCATIONS CONNECTING ACROSS BORDERS NEW YORK MADRID LONDON PARIS HAMBURG FRANKFURT MUNICH MILAN GLOBAL OFFICE HEADS ATHENS George Paleokrassas BANGKOK Steven Burkill
More informationPractical advice for rapidly and efficiently closing deals while managing risk
Practical advice for rapidly and efficiently closing deals while managing risk A leading national law firm for middle market M&A and private equity Top-ranked nationally by The Legal 500 and U.S. News
More informationMAJOR LEGAL TRENDS FOR 2016
MAJOR LEGAL TRENDS FOR 2016 JEGI Media & Technology Conference Robert Dickey January 14, 2016 2015 Morgan, Lewis & Bockius LLP IT S CARNIVAL TIME! 2015 Morgan, Lewis & Bockius LLP Disclaimers of Reliance
More informationVenture Capital Report
Venture Capital Report Europe 3Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included
More informationPE Monthly Roundup July 2017
PE Monthly Roundup y 20 PE/VC headline trends Monthly US$ mn # Investments,000 0 0 9,000 0 9 2 0 2,000 0 0,000 9,00,2, 92,02,9 9 2,,920,,0, 20-0 - Aug- Sep- Oct- Nov- Dec- Jan- Feb- Mar- - - - -,00,000
More information2014 Global venture capital confidence survey results
2014 Global venture capital confidence survey results How confident are investors? August 13, 2014 Contents Survey methodology, demographics and key findings Economic trends Regional and country investing
More informationDenis Brock Partner. Experience
Denis Brock Partner Hong Kong D: +852-3512-2388 dbrock@omm.com Denis Brock is the Chair of O'Melveny's International Disputes and Arbitration Practice and the regional head of the Asia Litigation Practice.
More informationPreparing For and Surviving an M&A Transaction
Preparing For and Surviving an M&A Transaction Understanding the Process and Avoiding Traps for the Unwary Diane Holt Frankle, Partner Nicholas O Keefe, Partner John Selig, Managing Partner, Mavericks
More informationmergers & acquisitions all your transactions are a big deal to us
mergers & acquisitions all your transactions are a big deal to us Did you know? The Takeover Panel is consulting on new powers to enable enforcement of post-offer undertakings in a public takeover offer.
More informationLife Sciences. An evolving industry: Today s clusters creating tomorrow s breakthroughs. New Jersey JLL Research
Life Sciences New Jersey 2017 An evolving industry: Today s clusters creating tomorrow s breakthroughs JLL Research 2 New Jersey Over the course of the past 130 years, the pharmaceutical/life sciences
More informationIVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.
IVC-MEITAR HIGH-TECH EXITS H1/ 215 REPORT IVC-Meitar 214 Exits Report Prepared by IVC Research Center Ltd. Israeli High-Tech Exit Highlights Exit proceeds in H1/215 reached ¾ of total exits for 214 Average
More informationMay 13, 2015 London Life Sciences College Cristina Menendez Ruiz
May 13, 2015 London Life Sciences College is open to in-house counsel, regulatory personnel at pharmaceutical companies and regulators. There is no registration fee to attend this exclusive event. For
More information- University of St. Gallen (M.A. HSG in Law, 2010) - London School of Economics and Political Science (LL.M., 2016)
David Weber M.A. HSG in Law, LL.M. Attorney at Law Senior Associate Languages: German, English, French Contact: +41 58 211 36 16, dweber@vischer.com General David Weber's practice focuses on banking and
More informationPatent. Fish &Richardson
Patent Fish &Richardson > > 0 >> A 5G2 > > 0 0 >> >> 1 8 0 9 G H 3 0 H O 9 P D 4 A 4 4 > 6 7 0 1 6 7 A B 9 3 spark INNOVATION, > * 7 / / / to a protected PORTFOLIO As one of the world s premier intellectual
More informationHalliburton and Baker Hughes Creating the leading oilfield services company
Halliburton and Baker Hughes Creating the leading oilfield services company Halliburton Investor Relations Contacts: Kelly Youngblood, Vice President Scott Danby, Manager 281.871.2688 or investors@halliburton.com
More informationSeale & Associates Creative Solutions. Trusted Advice. MERGERS & ACQUISITIONS MEXICO JUNE 2018 MONTHLY ISSUE
MERGERS & ACQUISITIONS MEXICO JUNE 2018 MONTHLY ISSUE MERGERS & ACQUISITIONS IN MEXICO In June 2018, 15 transactions were announced in Mexico, a decrease of 21% over last month. Also, total reported deal
More informationInternational Public Relations Group of Companies/Worldcom Fonds, Ontario Editorial Bureau Record Group Number:
Title: Creator: Dates of Material: Summary of Contents: International Public Relations Group of Companies/Worldcom Fonds, 1977-1989 Ontario Editorial Bureau 1987-1989 Record Group Number: RG 75-60 Correspondence,
More informationHow attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners
How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners How attractive is the BioRegion of Catalonia for foreign investment? M ost
More informationRecent marquee transactions
Recent marquee transactions EY the leading advisor in the Indian M&A market April 2014 EY refers to the global organization, and/or one or more of the independent member firms of Ernst & Young Global Limited
More informationTeresa V. Pahl Partner
Teresa represents clients in all phases and aspects of their businesses. Teresa s expertise includes matters involving general corporate law, securities law and real property law. Teresa works with early-stage
More information